The prevalence of use of medical devices in treating ailments is increasing with time. In many instances, and as these medical devices are made smaller, these medical devices are frequently implanted within a patient. While the desirability of implantable devices is increasing as the size of the devices has decreased, the implantation process still frequently requires complicated surgery which can expose the patient to significant risks and protracted recovery times. In light of this, further methods, systems, and devices are desired to increase the ease of implantation of medical devices, and the ease of use of such implanted medical devices.
One aspect of the present disclosure relates to a charger. The charger includes a charging coil, which charging coil is configured to magnetically couple with an implantable device to recharge the implantable device, a class E driver electrically connected to the charging coil, which class E driver includes a switching circuit that is switched by the application of a first voltage to the switching circuit, and a current sensor positioned to sense a current passing through the charging coil. The charger can include a processor electrically connected to the class E driver to receive data indicative of the current passing through the charging coil and electrically connected to the class E driver to control the switching circuit via the application of the first voltage to the switching circuit. In some embodiments, the processor can receive data indicative of the current passing through the charging coil and control the switching circuit in response to the received data.
In some embodiments, the switching circuit can be a transistor. In some embodiments, the transistor can be a MOSFET. In some embodiments, the processor is electrically connected to the class E driver to receive data indicative of a second voltage of the switching circuit. In some embodiments, the processor can receive data indicative of the second voltage of the switching circuit, and control the switching circuit in response to the received data indicative of the second voltage of the switching circuit.
In some embodiments, the second voltage is measured at the drain of the switching circuit and the first voltage is applied to the gate of the switching circuit. In some embodiments, the processor is electrically connected to the class E driver via a voltage divider including a first resistor and a second resistor. In some embodiments, the processor can sense a power switching transistor voltage, and determine whether to adjust a first frequency with which the first voltage is applied to the switching circuit, which adjustment of the first frequency mitigates one or several propagation delays.
In some embodiments, the processor can retrieve a stored value identifying a second frequency with which the first voltage is applied based on the sensed power switching transistor voltage. In some embodiments, the processor can compare the retrieved stored value identifying the second frequency with which the first voltage is applied to one or several frequency limits. In some embodiments, the first frequency is set to the second frequency if the second frequency does not exceed the one or several frequency limits. In some embodiments, when the second frequency exceeds one of the one or several frequency limits, the first frequency is set to the exceeded one of the one or several frequency limits.
One aspect of the present disclosure relates to a charger. The charger includes a charging coil that can generate a magnetic field having a frequency and can magnetically couple with an implantable device to recharge the implantable device, a class E driver electrically connected to the charging coil, and an FSK module that can modulate the frequency of the magnetic field among at least three frequencies.
In some embodiments, the at least three frequencies include a first frequency, a second frequency, and a third frequency. In some embodiments, the third frequency is the highest frequency and the second frequency is the lowest frequency. In some embodiments, the charger includes a processor electrically connected to the FSK module and that can control the FSK module. In some embodiments, the processor can selectively operate the charger in either a data non-transmitting state or in a data transmitting state.
In some embodiments, a carrier signal has the first frequency when the charger operates in the data non-transmitting state. In some embodiments, the processor controls the FSK module to modulate the carrier signal between the second frequency and the third frequency when the charger operates in the data transmitting state.
In some embodiments, the FSK module includes two capacitors and two transistors. In some embodiments, the two capacitors and the two transistors of the FSK module are electrically connected such that the two capacitors can be selectively included within the circuit by the FSK module. In some embodiments, the processor can control the two transistors of the FSK module to selectively include the two capacitors within the circuit by the FSK module. In some embodiments, the selective inclusion of the two capacitors within the circuit of the FSK modulates the frequency of the magnetic field between the first, second, and third frequencies.
One aspect of the present disclosure relates to a method of communicating with an implantable device during charging of the implantable device. The method includes generating a charging signal with a charging coil, which charging signal has an initial, first frequency, and transmitting data by modulating the frequency of the charging signal between a second frequency that is lower than the first frequency and a third frequency that is higher than the first frequency.
In some embodiments, the method can include generating transmission data, which can be the data that is transmitted. In some embodiments, the transmission data can be in binary format. In some embodiments, modulating the frequency of the charging signal between the second frequency and the third frequency transmits the transmission data in binary format.
In some embodiments, the frequency of the charging signal is modulated by an FSK module. In some embodiments, the FSK module can include two capacitors and two transistors. In some embodiments, the two capacitors and the two transistors of the FSK module are electrically connected such that the two capacitors can be selectively included within the circuit of by the FSK module to thereby modulate the frequency of the charging signal.
One aspect of the present disclosure relates to a method of controlling a charger. The method includes creating a magnetic coupling between a charger and an implantable device, which magnetic coupling charges the implantable device, setting an initial frequency of a drive signal, which frequency of the drive signal is set by a processor, and which drive signal controls the opening and closing of a switch, sensing a voltage at the switch at a first time, based on the voltage at the switch at the first time, retrieving a value identifying a second frequency, and changing the frequency of the drive signal.
In some embodiments, changing the frequency of the drive signal can include changing the frequency of the drive signal from the first frequency to the second frequency. In some embodiments, the method can include retrieving one or several frequency limits, which frequency limits provide an upper and lower bound to a range of acceptable frequencies of the drive signal. In some embodiments, the method can include comparing the second frequency to the one or several frequency limits.
In some embodiments, changing the frequency of the drive signal can include changing the frequency of the drive signal from the first frequency to the one of the one or several frequency limits if the second frequency exceeds the one of the one or several frequency limits. In some embodiments, changing the frequency of the drive signal can include changing the frequency of the drive signal from the first frequency to the second frequency if the second frequency does not exceed the one or several frequency limits. In some embodiments, changing of the frequency of the drive signal can mitigate an effect of a propagation delay. In some embodiments, the frequency of the drive signal can be adjusted multiple times to mitigate the effect of the propagation delay.
Further areas of applicability of the present disclosure will become apparent from the detailed description provided hereinafter. It should be understood that the detailed description and specific examples, while indicating various embodiments, are intended for purposes of illustration only and are not intended to necessarily limit the scope of the disclosure.
In the appended figures, similar components and/or features may have the same reference label. Where the reference label is used in the specification, the description is applicable to any one of the similar components having the same reference label.
A significant percentage of the Western (EU and US) population is affected by Neuropathic pain (chronic intractable pain due to nerve damage). In many people, this pain is severe. There are thousands of patients that have chronic intractable pain involving a nerve. Neuropathic pain can be very difficult to treat with only half of patients achieving partial relief. Thus, determining the best treatment for individual patients remains challenging. Conventional treatments include certain antidepressants, anti-epileptic drugs and opioids. However, side effects from these drugs can be detrimental. In some of these cases, electrical stimulation can provide effective treatment of this pain without the drug-related side effects.
A spinal cord stimulator is a device used to deliver pulsed electrical signals to the spinal cord to control chronic pain. Because electrical stimulation is a purely electrical treatment and does not cause side effects similar to those caused by drugs, an increasing number of physicians and patients favor the use of electrical stimulation over drugs as a treatment for pain. The exact mechanisms of pain relief by spinal cord stimulation (SCS) are unknown. Early SCS trials were based on the Gate Control Theory, which posits that pain is transmitted by two kinds of afferent nerve fibers. One is the larger myelinated Aδ fiber, which carries quick, intense-pain messages. The other is the smaller, unmyelinated “C” fiber, which transmits throbbing, chronic pain messages. A third type of nerve fiber, called Aβ, is “non-nociceptive,” meaning it does not transmit pain stimuli. The gate control theory asserts that signals transmitted by the Aδ and C pain fibers can be thwarted by the activation/stimulation of the non-nociceptive Aβ fibers and thus inhibit an individual's perception of pain. Thus, neurostimulation provides pain relief by blocking the pain messages before they reach the brain.
SCS is often used in the treatment of failed back surgery syndrome, a chronic pain syndrome that has refractory pain due to ischemia. SCS complications have been reported in a large portion, possibly 30% to 40%, of all SCS patients. This increases the overall costs of patient pain management and decreases the efficacy of SCS. Common complications include: infection, hemorrhaging, injury of nerve tissue, placing device into the wrong compartment, hardware malfunction, lead migration, lead breakage, lead disconnection, lead erosion, pain at the implant site, generator overheating, and charger overheating. The occurrence rates of common complications are surprisingly high: including lead extension connection issues, lead breakage, lead migration and infection.
Peripheral neuropathy, another condition that can be treated with electrical stimulation, may be either inherited or acquired. Causes of acquired peripheral neuropathy include physical injury (trauma) to a nerve, viruses, tumors, toxins, autoimmune responses, nutritional deficiencies, alcoholism, diabetes, and vascular and metabolic disorders. Acquired peripheral neuropathies are grouped into three broad categories: those caused by systemic disease, those caused by trauma, and those caused by infections or autoimmune disorders affecting nerve tissue. One example of an acquired peripheral neuropathy is trigeminal neuralgia, in which damage to the trigeminal nerve (the large nerve of the head and face) causes episodic attacks of excruciating, lightning-like pain on one side of the face.
A high percentage of patients with peripheral neuropathic pain do not benefit from SCS for various reasons. However, many of these patients can receive acceptable levels of pain relief via direct electrical stimulation to the corresponding peripheral nerves. This therapy is called peripheral nerve stimulation (PNS). As FDA approved PNS devices have not been commercially available in the US market, Standard spinal cord stimulator (SCS) devices are often used off label by pain physicians to treat this condition. A significant portion of SCS devices that have been sold may have been used off-label for PNS.
As current commercially-available SCS systems were designed for stimulating the spinal cord and not for peripheral nerve stimulation, there are more device complications associated with the use of SCS systems for PNS than for SCS. Current SCS devices (generators) are large and bulky. In the event that an SCS is used for PNS, the SCS generator is typically implanted in the abdomen or in the lower back above the buttocks and long leads are tunneled across multiple joints to reach the target peripheral nerves in the arms, legs or face. The excessive tunneling and the crossing of joints leads to increased post-surgical pain and higher device failure rates. Additionally, rigid leads can lead to skin erosion and penetration, with lead failure rates being far too high within the first few years of implantation. Many or even most complications result in replacement surgery and even multiple replacement surgeries in some cases.
One embodiment of an implantable neurostimulation system 100 is shown in
The implantable neurostimulation system 100 can include one or several pulse generators. The pulse generators can comprise a variety of shapes and sizes, and can be made from a variety of materials. In some embodiments, the one or several pulse generators can generate one or several non-ablative electrical pulses that are delivered to a nerve to control pain. In some embodiments, these pulses can have a pulse amplitude of between 0-1,000 mA, 0-100 mA, 0-50 mA, 0-25 mA, and/or any other or intermediate range of amplitudes. One or more of the pulse generators can include a processor and/or memory. In some embodiments, the processor can provide instructions to and receive information from the other components of the implantable neurostimulation system 100. The processor can act according to stored instructions, which stored instructions can be located in memory, associated with the processor, and/or in other components of the implantable neurostimulation system 100. The processor can, in accordance with stored instructions, make decisions. The processor can comprise a microprocessor, such as a microprocessor from Intel® or Advanced Micro Devices, Inc.®, or the like.
In some embodiments, the stored instructions directing the operation of the processor may be implemented by hardware, software, scripting languages, firmware, middleware, microcode, hardware description languages, and/or any combination thereof. When implemented in software, firmware, middleware, scripting language, and/or microcode, the program code or code segments to perform the necessary tasks may be stored in a machine readable medium such as a storage medium. A code segment or machine-executable instruction may represent a procedure, a function, a subprogram, a program, a routine, a subroutine, a module, a software package, a script, a class, or any combination of instructions, data structures, and/or program statements. A code segment may be coupled to another code segment or a hardware circuit by passing and/or receiving information, data, arguments, parameters, and/or memory contents. Information, arguments, parameters, data, etc. may be passed, forwarded, or transmitted via any suitable means including memory sharing, message passing, token passing, network transmission, etc.
In some embodiments, the memory of one or both of the pulse generators can be the storage medium containing the stored instructions. The memory may represent one or more memories for storing data, including read only memory (ROM), random access memory (RAM), magnetic RAM, core memory, magnetic disk storage mediums, optical storage mediums, flash memory devices and/or other machine readable mediums for storing information. In some embodiments, the memory may be implemented within the processor or external to the processor. In some embodiments, the memory can be any type of long term, short term, volatile, nonvolatile, or other storage medium and is not to be limited to any particular type of memory or number of memories, or type of media upon which memory is stored. In some embodiments, the memory can include, for example, one or both of volatile and nonvolatile memory. In one specific embodiment, the memory can include a volatile portion such as RAM memory, and a nonvolatile portion such as flash memory.
In some embodiments, one of the pulse generators can be an external pulse generator 102 or an implantable pulse generator 104. The external pulse generator 102 can be used to evaluate the suitability of a patient for treatment with the implantable neurostimulation system 100 and/or for implantation of an implantable pulse generator 104.
In some embodiments, one of the pulse generators can be the implantable pulse generator 104, which can be sized and shaped, and made of material to allow implantation of the implantable pulse generator 104 inside of a body. In some embodiments, the implantable pulse generator 104 can be sized and shaped so as to allow placement of the implantable pulse generator 104 at any desired location in a body, and in some embodiments, placed proximate to a peripheral nerve such that leads (discussed below) are not tunneled across joints and/or such that extension cables are not needed.
The implantable pulse generator 104 can include one or several energy storage features. In some embodiments, these features can be configured to store energy, such as, for example, electric energy, that can be used in the operation of the implantable pulse generator 104. These energy storage features can include, for example, one or several batteries, including rechargeable batteries, one or several capacitors, one or several fuel cells, or the like.
In some embodiments, the electrical pulses generated by the pulse generator can be delivered to one or several nerves 110 and/or to tissue proximate to one or several nerves 110 via one or several leads. The leads can include conductive portions, such as electrodes or contact portions of electrodes, and non-conductive portions. The leads can have a variety of shapes, can be a variety of sizes, and can be made from a variety of materials, which size, shape, and materials can be dictated by the application or other factors.
In some embodiments, the leads can include an anodic lead 106 and/or a cathodic lead 108. In some embodiments, the anodic lead 106 and the cathodic lead 108 can be identical leads, but can receive pulses of different polarity from the pulse generator.
In some embodiments, the leads can connect directly to the pulse generator, and in some embodiments, the leads can be connected to the pulse generator via a connector 112 and a connector cable 114. The connector 112 can comprise any device that is able to electrically connect the leads to the connector cable 114. Likewise, the connector cable can be any device capable of transmitting distinct electrical pulses to the anodic lead 106 and the cathodic lead 108.
In some embodiments, the implantable neurostimulation system 100 can include a charger 116 that can be configured to recharge the implantable pulse generator 104 when the implantable pulse generator 104 is implanted within a body. The charger 116 can comprise a variety of shapes, sizes, and features, and can be made from a variety of materials. Like the pulse generators 102, 104, the charger 116 can include a processor and/or memory having similar characteristics to those discussed above. In some embodiments, the charger 116 can recharge the implantable pulse generator 104 via an inductive coupling.
In some embodiments, one or several properties of the electrical pulses can be controlled via a controller. In some embodiments, these properties can include, for example, the frequency, strength, pattern, duration, or other aspects of the timing and magnitude of the electrical pulses. In one embodiment, these properties can include, for example, a voltage, a current, or the like. In one embodiment, a first electrical pulse can have a first property and a second electrical pulse can have a second property. This control of the electrical pulses can include the creation of one or several electrical pulse programs, plans, or patterns, and in some embodiments, this can include the selection of one or several pre-existing electrical pulse programs, plans, or patterns. In the embodiment depicted in
In some embodiments, the controller of the implantable neurostimulation system 100 can include a patient remote 120. The patient remote 120 can comprise a computing device that can communicate with the pulse generators via a wired or wireless connection. The patient remote 120 can be used to program the pulse generator, and in some embodiments, the patient remote 120 can include one or several pulse generation programs, plans, or patterns created by the clinician programmer 118. In some embodiments, the patient remote 120 can be used to select one or several of the pre-existing pulse generation programs, plans, or patterns and to select, for example, the duration of the selected one of the one or several pulse generation programs, plans, or patterns.
Advantageously, the above outlined components of the implantable neurostimulation system 100 can be used to control and provide the generation of electrical pulses to mitigate patient pain.
With reference now to
As will be described in greater detail below, in some embodiments, the charger 116 can directly communicate with the implantable pulse generator 104, without relying on the network 110. This communication is indicated in
With reference now to
In some embodiments, the pulse generator 102/104 can include, for example, a network interface 300, or alternatively, a communication module. The network interface 300, or alternatively, the communication module, can be configured to access the network 110 to allow communication between the pulse generator 102, 104 and the other components of the implantable neurostimulation system 100. In some embodiments, the network interface 300, or alternatively, a communication module, can include one or several antennas and software configured to control the one or several antennas to send information to and receive information from one or several of the other components of the implantable neurostimulation system 100.
The pulse generator 102, 104 can further include a data module 302. The data module 302 can be configured to manage data relating to the identity and properties of the pulse generator 102, 104. In some embodiments, the data module can include one or several databases that can, for example, include information relating to the pulse generator 102, 104 such as, for example, the identification of the pulse generator, one or several properties of the pulse generator 102, 104, or the like. In one embodiment, the data identifying the pulse generator 102, 104 can include, for example, a serial number of the pulse generator 102, 104 and/or other identifier of the pulse generator 102, 104 including, for example, a unique identifier of the pulse generator 102, 104. In some embodiments, the information associated with the property of the pulse generator 102, 104 can include, for example, data identifying the function of the pulse generator 102, 104, data identifying the power consumption of the pulse generator 102, 104, data identifying the charge capacity of the pulse generator 102, 104 and/or power storage capacity of the pulse generator 102, 104, data identifying potential and/or maximum rates of charging of the pulse generator 102, 104, and/or the like.
The pulse generator 102, 104 can include a pulse control 304. In some embodiments, the pulse control 304 can be configured to control the generation of one or several pulses by the pulse generator 102, 104. In some embodiments, for example, this information can identify one or several pulse patterns, programs, or the like. This information can further specify, for example, the frequency of pulses generated by the pulse generator 102, 104, the duration of pulses generated by the pulse generator 102, 104, the strength and/or magnitude of pulses generated by the pulse generator 102, 104, or any other details relating to the creation of one or several pulses by the pulse generator 102, 104. In some embodiments, this information can specify aspects of a pulse pattern and/or pulse program, such as, for example, the duration of the pulse pattern and/or pulse program, and/or the like. In some embodiments, information relating to and/or for controlling the pulse generation of the pulse generator 102, 104 can be stored within the memory.
The pulse generator 102, 104 can include a charging module 306. In some embodiments, the charging module 306 can be configured to control and/or monitor the charging/recharging of the pulse generator 102, 104. In some embodiments, for example, the charging module 306 can include one or several features configured to receive energy for recharging the pulse generator 102, 104 such as, for example, one or several inductive coils/features that can interact with one or several inductive coils/features of the charger 116 to create an inductive coupling to thereby recharge the pulse generator 102, 104.
In some embodiments, the charging module 306 can include hardware and/or software configured to monitor the charging of the pulse generator 102, 104. In some embodiments, the hardware can include, for example, a charging coil, which can be, for example, a receiving coil, configured to magnetically couple with a charging coil of the charger 116. In some embodiments, the pulse generator 102, 104 can be configured to receive and/or send data via FSK during charging of the pulse generator 102, 104.
The pulse generator 102, 104 can include an energy storage device 308. The energy storage device 308, which can include the energy storage features, can be any device configured to store energy and can include, for example, one or several batteries, capacitors, fuel cells, or the like. In some embodiments, the energy storage device 308 can be configured to receive charging energy from the charging module 306.
With reference now to
In some embodiments, the charger 116 can include, for example, a network interface 350, or alternatively, a communication module. The network interface 350, or alternatively, a communication module, can be configured to access the network 110 to allow communication between the charger 116 and the other components of the implantable neurostimulation system 100. In some embodiments, the network interface 350, or alternatively, a communication module, can include one or several antennas and software configured to control the one or several antennas to send information to and receive information from one or several of the other components of the implantable neurostimulation system 100.
The charger 116 can include a charging module 352. The charging module 352 can be configured to control and/or monitor the charging of one or several of the pulse generators 102, 104. In some embodiments, the charging module 352 can include one or several features configured to transmit energy during charging. In one embodiment, these can include one or several charging coils, which can be, for example, one or several transmitting coils, that can magnetically couple with the charging coil of the pulse generator 102, 104 to thereby recharge the pulse generator 102, 104. In some embodiments, the charging coil can be described by a plurality of parameters including, for example, inductance and/or a quality factor (Q). Similarly, in some embodiments, the magnetic coupling between the transmitting coil and the receiving coil can be described by one or more parameters including, for example, a coupling coefficient.
In some embodiments, charging module 352 of the charger 116 can be configured to send and/or receive data via FSK during charging of the pulse generator 102, 104. The details of these components of the charging module 352 will be discussed in greater detail below.
The charger 116 can include a data module 354. The data module 354 can be configured to manage data for transmission to the pulse generator 102, 104 and/or data received from the pulse generator 102, 104. This information can include, for example, updates to software on the pulse generator 102, 104, pulse patterns, updates relating to the user of the pulse generator 102, 104, or the like. In some embodiments, the data module 354 can be configured to generate transmission data, which can then be communicated to the implantable pulse generator 104. In some embodiments, transmission data is generated by converting data into an encoded form corresponding to the communication capabilities of the charging module 352. In one embodiment in which the charging module 352 can modulate between two frequencies to communicate data, the data can be converted to binary format.
With reference now to
In some embodiments, and in different circumstances, the charging module 352 may operate at one or several different frequencies. In some embodiments, the processor 502 allows for monitoring the frequency of operation of the charging circuit. In such an embodiment, the processor 502 can be used to control the frequencies of operation of the charging module 352 and to ensure that the frequencies of operation of the charging module are within a desired range or ranges. This can be particularly important in embodiments in which the range of operation frequencies is specified by, for example, a government or government agency. In such embodiments, the processor 502 can ensure operation within regulatory limits and can provide the ability to shut down the charging module 352 if it is operating out of frequency tolerances.
The processor 502 can be connected to a class E driver 504, which can be, for example, a class E type power converter. The class E driver 504 can be used to convert AC to DC. In some embodiments, the class E driver 504, can be an efficient circuit, which efficiency can be obtained by switching an active element (typically a FET, including a MOSFET) of the class E driver 504 fully on or off to thereby avoid the linear region of operation. In some embodiments, this switching can occur when both the voltage and current through the active element are at or near zero. In some embodiments, switching the active element on can occur when the dv/dt across the active element is zero, so that small errors in the switch timing or tuning of the matching network do not significantly degrade the circuit's efficiency. The details of the class E driver 504 will be discussed at greater length below.
As seen in
Additionally, in some embodiments, the class E driver can include, or be connected with an FSK module 508. In some embodiments, the FSK module can include one or several features that can be controlled by the processor 508 to modulate and/or change the frequency of the magnetic field created by the charging coil 506. In some embodiments, the FSK module 508 can be controlled to create at least 2 frequencies, at least 3 frequencies, at least 4 frequencies, at least 5 frequencies, and/or any other or intermediate number of frequencies. In one embodiment, the FSK module 508 can be controlled to switch between a first frequency, a second frequency, and a third frequency. In one embodiment, the first frequency can be an intermediate frequency, with the second frequency being a relatively lower frequency and the third frequency being a relatively higher frequency. The details of the FSK module 508 will be discussed at greater length below.
With reference now to
The class E driver 504 comprises a power switching transistor (SW1), which can be, for example, a FET transistor. The power switching transistor (SW1) can have a drain (D1) connected to inductor (L1) which acts as a current source to supply DC power to the class E driver 504, a source (Si) connected to ground 602, and a gate (G1) connected to the processor 502. In some embodiments, processor 502 can control the power switching transistor (SW1) by varying the degree to which, or whether a voltage is applied to the gate (G1). The voltage applied to the gate (G1) is identified as drive signal (VG1) in
The class E driver 504 can include a load matching network 604 that can include capacitors (Cs) and (Cp), and charging coil (L2). In some embodiments, the properties of the load matching network 604, and of capacitors (Cs) and (Cp) and charging coil (L2) can, in combination with other components of the class E driver 504, give the charging circuit 500 a natural frequency, which can be an impulse response frequency.
In some embodiments, and as mentioned above, the charging coil (L2) can be a component of the load matching network 604, and can also be the transmitting coil that magnetically couples with the receiving coil of the implantable pulse generator 104. In such an embodiment, coil current (IL2) passes through charging coil (L2) and creates a magnetic field which can couple with the receiving coil of the implantable pulse generator 104.
The class E driver 504 can include a current sensor (T1) in some embodiments, and as depicted in
In some embodiments, the processor 502 can be connected to the class E driver 504 via a switch voltage circuit 606. In some embodiments, the switch voltage circuit 606 can comprise an electrical connection between the drain side of power switching transistor (SW1) and the processor 502. In some embodiments, the switch voltage circuit 606 can comprise features to adjust the voltage measured at the drain side of the power switching transistor (SW1) so that the voltage received at the processor 502 is compatible with the processor 502. In some embodiments, this may include use of an amplifier if the voltage at the drain side of the power switching transistor (SW1) is too low, and in some embodiments, this may include the use of one or several voltage reduction features if the voltage at the drain side of the power switching transistor (SW1) is too high. In the embodiment depicted in
In some embodiments, the processor 502 and the class E driver 504, including the charging coil 506, can operate as follows. Power is supplied to the class E-driver 504 via the inductor (L1), which acts as a current source. Coil current (IL2) is provided to the charging coil (L2), which current produces a magnetic field that can magnetically couple with the receiving coil of the implantable pulse generator 104 to recharge the implantable pulse generator. The load current (IL2) is sensed by the current sensor (T1), and in some embodiments, buffered and squared up, and provided to the processor 502. The processor 502 monitors the zero crossing current transitions of load current (IL2) and adjusts the drive signal (VG1) to the gate (G1) of the switching power transistor (SW1). The use of the processor 502 allows for both the on and off transitions of SW1 to be optimized for efficiency, and allows for these points to change as the operating frequency changes to maintain closer control of the circuit.
In some embodiments, the processor 502 can adjust one or both of the on and off times for power switching transistor (SW1) to maximize efficiency at all conditions of magnetic coupling and external influences on the transmitting coil. For example, if it is desired to switch on power switching transistor (SW1) before the zero crossing signal is received at the processor 502, then the timing can be adjusted for the next cycle based on the last cycle or last few cycles of the feedback signal from current sensor (T1). Additional feedback on circuit operation can also be obtained from the switch voltage circuit 606, which monitors the voltage across the power switching transistor (SW1). In some embodiments, the data from the switch voltage circuit 606 can used to control the power switching transistor (SW1), with a turn on point based on the minimum voltage across the FET. In some embodiments, the switch voltage circuit 606 can be configured to provide feedback on the peak amplitude of the power switching transistor's (SW1) drain voltage, as a check that the class E driver 504 is operating normally and help ensure safe and reliable operation.
In some embodiments, and as depicted in
In the embodiment depicted in
In some embodiments, and as depicted in
With reference now to
As depicted in
With reference now to
Chart 800 depicts a second trace 804 that corresponds to the drive signal (VG1). As seen in chart 800, the drive signal (VG1) can comprise a repeated boxcar function. In some embodiments, the second trace can comprise a first position 806, at which position the power switching transistor (SW1) is open, and a second position 808, at which position the power switching transistor (SW1) is closed. In some embodiments, the drive signal (VG1) can be characterized by a frequency with which the subsequent second position 808 corresponding to the power switching transistor (SW1) closed times occurs, and a length of time in which the drive signal (VG1) remains in the second position 808.
Chart 800 depicts a third trace 810 that corresponds to the current sensed by current sensor T1, with voltage clamping applied. As seen, the combination of this current output and the voltage clamping results in a periodic, truncated function. Chart 800 identifies the time 812 at which the current sensor T1 senses the zero crossing current transition of time 803. As seen, time 803 and time 812 are separated by a propagation delay (DY1).
Chart 800 depicts a fourth trace 814 that corresponds to the output from the buffer to T1 and input into the processor 502. This fourth trace 814 further corresponds to buffer affected output based on the third trace 810. The fourth trace 814 can be a repeated boxcar function having a first level 816 and a second level 818. As seen in chart 800, time 820 identifies the instant of the first transition from the first level 816 to the second level 818 after the zero crossing current transition of the coil current (IL2) at time 803. The temporal separation between time 820 and time 812 is propagation delay (DY2).
In addition to delays (DY1, DY2), two additional propagation delays arise in the operation of charging circuit 500. In one embodiment, these delays can include (1) processing time taken by the processor 502, and (2) the turn-on time of the power switching transistor (SW1). In some embodiments, these propagation delays can adversely affect the operation of the charging circuit 500, because immediate correction of improper timing cannot be made using presently utilized control methods. In the prior art, by the time the need for a timing change is identified, the proper time to make that change has passed. In one embodiment, and to counteract these propagation delays, the processor 502 can comprise a table identifying different frequencies for drive signal (VG1) and/or different lengths of time in which the drive signal (VG1) can remain in the second position 808. In some embodiments, the values in this table can be generated during evaluation of the charging circuit 500 under different load conditions which can, for example, replicate different magnetic couplings with the implantable pulse generator. By using processor control to implement a change in drive signal timing, which results in a change of the frequency of the drive signal (VG1) and/or different lengths of time in which the drive signal (VG1) is in the second position 808, the drive signal enters the second position 808 in the next (or later) cycle of the coil driving circuit, such as shown in
Chart 900 depicts a second trace 906 that corresponds to the drive signal (VG1). As seen in chart 900, the drive signal (VG1) can comprise a repeated boxcar function. In some embodiments, the second trace 906 can comprise a first position 908, at which position the power switching transistor (SW1) is open, and a second position 910, at which position the power switching transistor (SW1) is closed. In some embodiments, the closing of the power switching transistor (SW1) can connect the drain (D1) to ground 602 via source (Si). This connection can drive the voltage across the power switching transistor (SW1) to zero.
Chart 900 further depicts a third trace 912 corresponding to the sensed voltage across power switching transistor (SW1). The third trace 912 has a first, sinusoidal portion 914, and a second, flat portion 916. In some embodiments, the first, sinusoidal portion 914 of the third trace 912 indicates the varying voltage across the power switching transistor (SW1), and the second, flat portion 916 can identify the voltage across the power switching transistor (SW1) after the power switching transistor (SW1) is closed, which voltage, in the embodiment of
Chart 1000 of
Chart 1000 depicts a third trace 1012 corresponding to the sensed voltage across power switching transistor (SW1). The third trace 1012 has a first, sinusoidal portion 1014, and a second, flat portion 1018. As seen in chart 1000, as the frequency of the drive signal (VG1) is too low, the voltage indicated by the third trace 1012 drops below zero before the power switching transistor (SW1) is closed, and jumps via step 1018 to a zero voltage when the power switching transistor (SW1) is closed.
Chart 1100 of
Chart 1100 depicts a third trace 1112 corresponding to the sensed voltage across power switching transistor (SW1). The third trace 1112 has a first, sinusoidal portion 1114, and a second, flat portion 1118. As seen in chart 1100, as the frequency of the drive signal (VG1) is too high, the voltage indicated by the third trace 1012 does not reach zero before the power switching transistor (SW1) is closed, and jumps via step 1118 to a zero voltage when the power switching transistor (SW1) is closed. In the embodiments of
With reference now to
After the initial frequency of the drive signal (VG1) is set, the process 1200 proceeds to decision state 1204, wherein it is determined if a current zero-crossing transition has occurred. In some embodiments, this determination can be made based on data received from the current sensor (T1). If it is determined that no current zero-crossing transition has occurred, the process 1200 waits a length of time which length of time can be, for example, predetermined, and then returns to decision state 1204.
If it is determined that a current zero-crossing transition has occurred, the process 1200 proceeds to block 1206 wherein the power switching transistor voltage is sensed or read. In some embodiments, this voltage can be read from the switch voltage circuit 606. In some embodiments, the reading of the power switching transistor voltage can include determining whether the voltage at the power switching transistor (SW1) at the instant before and/or of the closing of the power switching transistor (SW1) is greater than, less than, or equal to the voltage at the power switching transistor (SW1) after the closing of the power switching transistor (SW1). In some embodiments, the voltage of the power switching transistor can be read at a first time that corresponds to the current zero-crossing.
After the power switching transistor voltage has been read, the process 1200 proceeds to block 1208 wherein the switching time corresponding to the read power switching transistor voltage is read. In some embodiments, this switching time can be the frequency of the drive signal (VG1). The switching time can be read from an entry in a table of switching times, which table of switching times can be generated by analyzing the charging circuit 500 under a variety of circumstances and load conditions. In some embodiments, this step can result in retrieving a value for adjusting the frequency of the drive signal (VG1) to more closely match the properties and/or load conditions of the charging circuit 500.
After the switch time corresponding to the read voltage of the power switching transistor (SW1) is retrieved, the process 1200 proceeds to block 1210, wherein frequency limits are retrieved. In some embodiments, the frequency limits can correspond to one or several limits on the frequencies of operation of the charging circuit 500 such as, for example, one or several legal limits, regulatory limits, or the like. In one embodiment, for example, the frequency limits can correspond to one or both of an upper limit (high limit) and a lower limit (low limit).
After the frequency limits have been retrieved, the process 1200 proceeds to block 1212, wherein the frequency limits are compared to the retrieved corresponding switching time. In some embodiments, this comparison can be performed by the processor of the charger 116. After the frequency limits are compared to the switching time, the process 1200 proceeds to decision state 1214, wherein it is determined if the retrieved corresponding switching time is within the frequency limits. This comparison can be performed by the processor of the charger 116.
If it is determined that the retrieved corresponding switching time is not within the frequency limits, the process 1200 proceeds to block 1216, wherein the switching time is set to one of the upper and lower frequency limits. In some embodiment, the one of the upper and lower frequency limits can be whichever of the upper frequency limit and the lower frequency limit is implicated in decision state 1214. After the switching time has been set to one of the upper and lower frequency limits, or returning to decision state 1214, if it is determined that the switching time is within the frequency limits, then the process 1200 proceeds to block 1218, wherein the switching time is applied in that the frequency of the drive signal (VG1) is set to the retrieved corresponding switching time. After the switching time has been applied, the process 1200 returns to decision state 1204, and proceeds as outlined above. In some embodiments, and as is the case with propagation delays, the cycle can be repeated multiple times until a switching time is identified that mitigates the propagation delays and corresponds to the functioning of the charging circuit 500. In some embodiments, and after a switching time has been identified that satisfactorily mitigates the propagation delays and/or the effects of the propagation delays, the charging circuit 500 can be operated at a steady state at that switching time.
In the foregoing specification, the invention is described with reference to specific embodiments thereof, but those skilled in the art will recognize that the invention is not limited thereto. Various features and aspects of the above-described invention can be used individually or jointly. Further, the invention can be utilized in any number of environments and applications beyond those described herein without departing from the broader spirit and scope of the specification. The specification and drawings are, accordingly, to be regarded as illustrative rather than restrictive. It will be recognized that the terms “comprising,” “including,” and “having,” as used herein, are specifically intended to be read as open-ended terms of art.
This application is a continuation of U.S. application Ser. No. 16/563,654 entitled “MICROPROCESSOR CONTROLLED CLASS E DRIVER,” and filed on Sep. 6, 2019, which is a continuation of U.S. application Ser. No. 15/685,874 entitled “MICROPROCESSOR CONTROLLED CLASS E DRIVER,” filed on Aug. 24, 2017 and issued as U.S. Pat. No. 10,447,083, which is a divisional of U.S. application Ser. No. 14/446,294 entitled “MICROPROCESSOR CONTROLLED CLASS E DRIVER,” filed on Jul. 29, 2014 and issued as U.S. Pat. No. 9,780,596, which claims the benefit of U.S. Provisional Application No. 61/859,471 entitled “MICROPROCESSOR CONTROLLED CLASS E DRIVER,” and filed on Jul. 29, 2013, the entirety of each of which are hereby incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
3057356 | Greatbatch | Oct 1962 | A |
3348548 | Chardack | Oct 1967 | A |
3646940 | Timm et al. | Mar 1972 | A |
3824129 | Fagan, Jr. | Jul 1974 | A |
3825015 | Berkovits | Jul 1974 | A |
3888260 | Fischell | Jun 1975 | A |
3902501 | Citron et al. | Sep 1975 | A |
3939843 | Smyth | Feb 1976 | A |
3942535 | Schulman | Mar 1976 | A |
3970912 | Hoffman | Jul 1976 | A |
3995623 | Blake et al. | Dec 1976 | A |
4019518 | Maurer et al. | Apr 1977 | A |
4044774 | Corbin et al. | Aug 1977 | A |
4082097 | Mann et al. | Apr 1978 | A |
4141365 | Fischell et al. | Feb 1979 | A |
4166469 | Littleford | Sep 1979 | A |
4269198 | Stokes | May 1981 | A |
4285347 | Hess | Aug 1981 | A |
4340062 | Thompson et al. | Jul 1982 | A |
4379462 | Borkan et al. | Apr 1983 | A |
4407303 | Akerstrom | Oct 1983 | A |
4437475 | White | Mar 1984 | A |
4468723 | Hughes | Aug 1984 | A |
4512351 | Pohndorf | Apr 1985 | A |
4550731 | Batina et al. | Nov 1985 | A |
4558702 | Barreras et al. | Dec 1985 | A |
4654880 | Sontag | Mar 1987 | A |
4662382 | Sluetz et al. | May 1987 | A |
4673867 | Davis | Jun 1987 | A |
4719919 | Marchosky et al. | Jan 1988 | A |
4721118 | Harris | Jan 1988 | A |
4722353 | Sluetz | Feb 1988 | A |
4744371 | Harris | May 1988 | A |
4800898 | Hess et al. | Jan 1989 | A |
4848352 | Pohndorf et al. | Jul 1989 | A |
4860446 | Lessar et al. | Aug 1989 | A |
4957118 | Erlebacher | Sep 1990 | A |
4989617 | Memberg et al. | Feb 1991 | A |
5012176 | Laforge | Apr 1991 | A |
5052407 | Hauser et al. | Oct 1991 | A |
5143089 | Alt | Sep 1992 | A |
5193539 | Schulman et al. | Mar 1993 | A |
5197466 | Marchosky et al. | Mar 1993 | A |
5204611 | Nor et al. | Apr 1993 | A |
5255691 | Otten | Oct 1993 | A |
5257634 | Kroll | Nov 1993 | A |
5342408 | Decoriolis et al. | Aug 1994 | A |
5439485 | Mar et al. | Aug 1995 | A |
5450088 | Meier et al. | Sep 1995 | A |
5476499 | Hirschberg | Dec 1995 | A |
5484445 | Knuth | Jan 1996 | A |
5558097 | Jacob et al. | Sep 1996 | A |
5571148 | Loeb et al. | Nov 1996 | A |
5592070 | Mino | Jan 1997 | A |
5637981 | Nagai et al. | Jun 1997 | A |
5676162 | Larson, Jr. et al. | Oct 1997 | A |
5690693 | Wang et al. | Nov 1997 | A |
5702428 | Tippey et al. | Dec 1997 | A |
5702431 | Wang et al. | Dec 1997 | A |
5712795 | Layman et al. | Jan 1998 | A |
5713939 | Nedungadi et al. | Feb 1998 | A |
5733313 | Barreras, Sr. et al. | Mar 1998 | A |
5735887 | Barreras, Sr. et al. | Apr 1998 | A |
5741316 | Chen et al. | Apr 1998 | A |
5755748 | Borza | May 1998 | A |
5871532 | Schroeppel | Feb 1999 | A |
5876423 | Braun | Mar 1999 | A |
5877472 | Campbell et al. | Mar 1999 | A |
5902331 | Bonner et al. | May 1999 | A |
5948006 | Mann | Sep 1999 | A |
5949632 | Barreras, Sr. et al. | Sep 1999 | A |
5957965 | Moumane et al. | Sep 1999 | A |
5991665 | Wang et al. | Nov 1999 | A |
6027456 | Feler et al. | Feb 2000 | A |
6035237 | Schulman et al. | Mar 2000 | A |
6055456 | Gerber | Apr 2000 | A |
6057513 | Ushikoshi et al. | May 2000 | A |
6067474 | Schulman et al. | May 2000 | A |
6075339 | Reipur et al. | Jun 2000 | A |
6076017 | Taylor et al. | Jun 2000 | A |
6081097 | Seri et al. | Jun 2000 | A |
6083247 | Rutten et al. | Jul 2000 | A |
6104957 | Alo et al. | Aug 2000 | A |
6104960 | Duysens et al. | Aug 2000 | A |
6138681 | Chen et al. | Oct 2000 | A |
6164284 | Schulman et al. | Dec 2000 | A |
6165180 | Cigaina et al. | Dec 2000 | A |
6166518 | Echarri et al. | Dec 2000 | A |
6169387 | Kaib | Jan 2001 | B1 |
6172556 | Prentice | Jan 2001 | B1 |
6178353 | Griffith et al. | Jan 2001 | B1 |
6181105 | Cutolo et al. | Jan 2001 | B1 |
6185452 | Schulman et al. | Feb 2001 | B1 |
6191365 | Avellanet | Feb 2001 | B1 |
6208894 | Schulman et al. | Mar 2001 | B1 |
6212430 | Kung | Apr 2001 | B1 |
6212431 | Hahn et al. | Apr 2001 | B1 |
6221513 | Lasater | Apr 2001 | B1 |
6227204 | Baumann et al. | May 2001 | B1 |
6243608 | Pauly et al. | Jun 2001 | B1 |
6246911 | Seligman | Jun 2001 | B1 |
6249703 | Stanton et al. | Jun 2001 | B1 |
6265789 | Honda et al. | Jul 2001 | B1 |
6275737 | Mann | Aug 2001 | B1 |
6278258 | Echarri et al. | Aug 2001 | B1 |
6305381 | Weijand et al. | Oct 2001 | B1 |
6306100 | Prass | Oct 2001 | B1 |
6313779 | Leung et al. | Nov 2001 | B1 |
6315721 | Schulman et al. | Nov 2001 | B2 |
6316909 | Honda et al. | Nov 2001 | B1 |
6321118 | Hahn | Nov 2001 | B1 |
6324430 | Zarinetchi et al. | Nov 2001 | B1 |
6324431 | Zarinetchi et al. | Nov 2001 | B1 |
6327504 | Dolgin et al. | Dec 2001 | B1 |
6341073 | Lee | Jan 2002 | B1 |
6354991 | Gross et al. | Mar 2002 | B1 |
6360750 | Gerber et al. | Mar 2002 | B1 |
6381496 | Meadows et al. | Apr 2002 | B1 |
6389318 | Zarinetchi et al. | May 2002 | B1 |
6393325 | Mann et al. | May 2002 | B1 |
6415186 | Chim et al. | Jul 2002 | B1 |
6427086 | Fischell et al. | Jul 2002 | B1 |
6438423 | Rezai et al. | Aug 2002 | B1 |
6442434 | Zarinetchi et al. | Aug 2002 | B1 |
6453198 | Torgerson et al. | Sep 2002 | B1 |
6466817 | Kaula et al. | Oct 2002 | B1 |
6473652 | Sarwal et al. | Oct 2002 | B1 |
6500141 | Irion et al. | Dec 2002 | B1 |
6505075 | Weiner | Jan 2003 | B1 |
6505077 | Kast et al. | Jan 2003 | B1 |
6510347 | Borkan | Jan 2003 | B2 |
6516227 | Meadows et al. | Feb 2003 | B1 |
6517227 | Stidham et al. | Feb 2003 | B2 |
6521350 | Fey et al. | Feb 2003 | B2 |
6542846 | Miller et al. | Apr 2003 | B1 |
6553263 | Meadows et al. | Apr 2003 | B1 |
6564807 | Schulman et al. | May 2003 | B1 |
6584355 | Stessman | Jun 2003 | B2 |
6600954 | Cohen et al. | Jul 2003 | B2 |
6609031 | Law et al. | Aug 2003 | B1 |
6609032 | Woods et al. | Aug 2003 | B1 |
6609945 | Jimenez et al. | Aug 2003 | B2 |
6652449 | Gross et al. | Nov 2003 | B1 |
6662051 | Eraker et al. | Dec 2003 | B1 |
6664763 | Echarri et al. | Dec 2003 | B2 |
6685638 | Taylor et al. | Feb 2004 | B1 |
6701188 | Stroebel et al. | Mar 2004 | B2 |
6721603 | Zabara et al. | Apr 2004 | B2 |
6735474 | Loeb et al. | May 2004 | B1 |
6745077 | Griffith et al. | Jun 2004 | B1 |
6809701 | Amundson et al. | Oct 2004 | B2 |
6836684 | Rijkhoff et al. | Dec 2004 | B1 |
6847849 | Mamo et al. | Jan 2005 | B2 |
6864755 | Moore | Mar 2005 | B2 |
6885894 | Stessman | Apr 2005 | B2 |
6892098 | Ayal et al. | May 2005 | B2 |
6895280 | Meadows et al. | May 2005 | B2 |
6896651 | Gross et al. | May 2005 | B2 |
6901287 | Davis et al. | May 2005 | B2 |
6941171 | Mann et al. | Sep 2005 | B2 |
6971393 | Mamo et al. | Dec 2005 | B1 |
6986453 | Jiang et al. | Jan 2006 | B2 |
6989200 | Byers et al. | Jan 2006 | B2 |
6990376 | Tanagho et al. | Jan 2006 | B2 |
6999819 | Swoyer et al. | Feb 2006 | B2 |
7051419 | Schrom et al. | May 2006 | B2 |
7054689 | Whitehurst et al. | May 2006 | B1 |
7069081 | Biggs et al. | Jun 2006 | B2 |
7114502 | Schulman et al. | Oct 2006 | B2 |
7127298 | He et al. | Oct 2006 | B1 |
7131996 | Wasserman et al. | Nov 2006 | B2 |
7142925 | Bhadra et al. | Nov 2006 | B1 |
7146219 | Sieracki et al. | Dec 2006 | B2 |
7151914 | Brewer | Dec 2006 | B2 |
7167749 | Biggs et al. | Jan 2007 | B2 |
7167756 | Torgerson et al. | Jan 2007 | B1 |
7177690 | Woods et al. | Feb 2007 | B2 |
7177698 | Klosterman et al. | Feb 2007 | B2 |
7181286 | Sieracki et al. | Feb 2007 | B2 |
7184836 | Meadows et al. | Feb 2007 | B1 |
7187978 | Malek et al. | Mar 2007 | B2 |
7191005 | Stessman | Mar 2007 | B2 |
7212110 | Martin et al. | May 2007 | B1 |
7225028 | Della Santina et al. | May 2007 | B2 |
7225032 | Schmeling et al. | May 2007 | B2 |
7231254 | DiLorenzo | Jun 2007 | B2 |
7234853 | Givoletti | Jun 2007 | B2 |
7239918 | Strother et al. | Jul 2007 | B2 |
7245972 | Davis | Jul 2007 | B2 |
7286880 | Olson et al. | Oct 2007 | B2 |
7295878 | Meadows et al. | Nov 2007 | B1 |
7305268 | Gliner et al. | Dec 2007 | B2 |
7317948 | King et al. | Jan 2008 | B1 |
7324852 | Barolat et al. | Jan 2008 | B2 |
7324853 | Ayal et al. | Jan 2008 | B2 |
7328068 | Spinelli et al. | Feb 2008 | B2 |
7330764 | Swoyer et al. | Feb 2008 | B2 |
7331499 | Jiang et al. | Feb 2008 | B2 |
7359751 | Erickson et al. | Apr 2008 | B1 |
7369894 | Gerber | May 2008 | B2 |
7386348 | North et al. | Jun 2008 | B2 |
7387603 | Gross et al. | Jun 2008 | B2 |
7396265 | Darley et al. | Jul 2008 | B2 |
7415308 | Gerber et al. | Aug 2008 | B2 |
7444181 | Shi et al. | Oct 2008 | B2 |
7444184 | Boveja et al. | Oct 2008 | B2 |
7450991 | Smith et al. | Nov 2008 | B2 |
7460911 | Cosendai et al. | Dec 2008 | B2 |
7463928 | Lee et al. | Dec 2008 | B2 |
7470236 | Kelleher et al. | Dec 2008 | B1 |
7483752 | Von Arx et al. | Jan 2009 | B2 |
7486048 | Tsukamoto et al. | Feb 2009 | B2 |
7496404 | Meadows et al. | Feb 2009 | B2 |
7513257 | Schulman et al. | Apr 2009 | B2 |
7515967 | Phillips et al. | Apr 2009 | B2 |
7525293 | Notohamiprodjo et al. | Apr 2009 | B1 |
7532936 | Erickson et al. | May 2009 | B2 |
7539538 | Parramon et al. | May 2009 | B2 |
7551960 | Forsberg et al. | Jun 2009 | B2 |
7555346 | Woods et al. | Jun 2009 | B1 |
7565203 | Greenberg et al. | Jul 2009 | B2 |
7578819 | Bleich et al. | Aug 2009 | B2 |
7580752 | Gerber et al. | Aug 2009 | B2 |
7582053 | Gross et al. | Sep 2009 | B2 |
7599743 | Hassler, Jr. et al. | Oct 2009 | B2 |
7617002 | Goetz | Nov 2009 | B2 |
7636602 | Baru Fassio et al. | Dec 2009 | B2 |
7640059 | Forsberg et al. | Dec 2009 | B2 |
7643880 | Tanagho et al. | Jan 2010 | B2 |
7650192 | Wahlstrand | Jan 2010 | B2 |
7706889 | Gerber et al. | Apr 2010 | B2 |
7720547 | Denker et al. | May 2010 | B2 |
7725191 | Greenberg et al. | May 2010 | B2 |
7734355 | Cohen et al. | Jun 2010 | B2 |
7738963 | Hickman et al. | Jun 2010 | B2 |
7738965 | Phillips et al. | Jun 2010 | B2 |
7747330 | Nolan et al. | Jun 2010 | B2 |
7771838 | He et al. | Aug 2010 | B1 |
7774069 | Olson et al. | Aug 2010 | B2 |
7801619 | Gerber et al. | Sep 2010 | B2 |
7813803 | Heruth et al. | Oct 2010 | B2 |
7813809 | Strother et al. | Oct 2010 | B2 |
7826901 | Lee et al. | Nov 2010 | B2 |
7848818 | Barolat et al. | Dec 2010 | B2 |
7878207 | Goetz et al. | Feb 2011 | B2 |
7880337 | Farkas | Feb 2011 | B2 |
7904167 | Klosterman et al. | Mar 2011 | B2 |
7912547 | Tseng et al. | Mar 2011 | B2 |
7912555 | Swoyer et al. | Mar 2011 | B2 |
7925357 | Phillips et al. | Apr 2011 | B2 |
7932696 | Peterson | Apr 2011 | B2 |
7933656 | Sieracki et al. | Apr 2011 | B2 |
7935051 | Miles et al. | May 2011 | B2 |
7937158 | Erickson et al. | May 2011 | B2 |
7952349 | Huang et al. | May 2011 | B2 |
7957818 | Swoyer | Jun 2011 | B2 |
7979119 | Kothandaraman et al. | Jul 2011 | B2 |
7979126 | Payne et al. | Jul 2011 | B2 |
7988507 | Darley et al. | Aug 2011 | B2 |
8000782 | Gharib et al. | Aug 2011 | B2 |
8000800 | Takeda et al. | Aug 2011 | B2 |
8000805 | Swoyer et al. | Aug 2011 | B2 |
8005535 | Gharib et al. | Aug 2011 | B2 |
8005549 | Boser et al. | Aug 2011 | B2 |
8005550 | Boser et al. | Aug 2011 | B2 |
8019423 | Possover | Sep 2011 | B2 |
8024047 | Olson et al. | Sep 2011 | B2 |
8036756 | Swoyer et al. | Oct 2011 | B2 |
8044635 | Peterson | Oct 2011 | B2 |
8050769 | Gharib et al. | Nov 2011 | B2 |
8055337 | Moffitt et al. | Nov 2011 | B2 |
8068912 | Kaula et al. | Nov 2011 | B2 |
8083663 | Gross et al. | Dec 2011 | B2 |
8103360 | Foster | Jan 2012 | B2 |
8116862 | Stevenson et al. | Feb 2012 | B2 |
8121701 | Woods et al. | Feb 2012 | B2 |
8129942 | Park et al. | Mar 2012 | B2 |
8131358 | Moffitt et al. | Mar 2012 | B2 |
8140168 | Olson et al. | Mar 2012 | B2 |
8145324 | Stevenson et al. | Mar 2012 | B1 |
8150530 | Wesselink | Apr 2012 | B2 |
8175717 | Haller et al. | May 2012 | B2 |
8180451 | Hickman et al. | May 2012 | B2 |
8180452 | Shaquer | May 2012 | B2 |
8180461 | Mamo et al. | May 2012 | B2 |
8214042 | Ozawa et al. | Jul 2012 | B2 |
8214048 | Whitehurst et al. | Jul 2012 | B1 |
8214051 | Sieracki et al. | Jul 2012 | B2 |
8217535 | Uchida et al. | Jul 2012 | B2 |
8219196 | Torgerson | Jul 2012 | B2 |
8219202 | Giftakis et al. | Jul 2012 | B2 |
8219205 | Tseng et al. | Jul 2012 | B2 |
8224460 | Schleicher et al. | Jul 2012 | B2 |
8233990 | Goetz | Jul 2012 | B2 |
8255057 | Fang et al. | Aug 2012 | B2 |
8310108 | Inoue et al. | Nov 2012 | B2 |
8311636 | Gerber et al. | Nov 2012 | B2 |
8314594 | Scott et al. | Nov 2012 | B2 |
8332040 | Winstrom | Dec 2012 | B1 |
8340786 | Gross et al. | Dec 2012 | B2 |
8362742 | Kallmyer | Jan 2013 | B2 |
8369943 | Shuros et al. | Feb 2013 | B2 |
8386048 | McClure et al. | Feb 2013 | B2 |
8417346 | Giftakis et al. | Apr 2013 | B2 |
8423146 | Giftakis et al. | Apr 2013 | B2 |
8447402 | Jiang et al. | May 2013 | B1 |
8447408 | North et al. | May 2013 | B2 |
8457756 | Rahman | Jun 2013 | B2 |
8457758 | Olson et al. | Jun 2013 | B2 |
8467875 | Bennett et al. | Jun 2013 | B2 |
8480437 | Dilmaghanian et al. | Jul 2013 | B2 |
8494625 | Hargrove | Jul 2013 | B2 |
8515545 | Trier | Aug 2013 | B2 |
8538530 | Orinski | Sep 2013 | B1 |
8543223 | Sage et al. | Sep 2013 | B2 |
8544322 | Minami et al. | Oct 2013 | B2 |
8549015 | Barolat | Oct 2013 | B2 |
8554322 | Olson et al. | Oct 2013 | B2 |
8555894 | Schulman et al. | Oct 2013 | B2 |
8562539 | Marino | Oct 2013 | B2 |
8571677 | Torgerson et al. | Oct 2013 | B2 |
8577474 | Rahman et al. | Nov 2013 | B2 |
8588917 | Whitehurst et al. | Nov 2013 | B2 |
8612002 | Faltys et al. | Dec 2013 | B2 |
8620436 | Parramon et al. | Dec 2013 | B2 |
8626314 | Swoyer et al. | Jan 2014 | B2 |
8644933 | Ozawa et al. | Feb 2014 | B2 |
8655451 | Klosterman et al. | Feb 2014 | B2 |
8700175 | Fell | Apr 2014 | B2 |
8706254 | Vamos et al. | Apr 2014 | B2 |
8725262 | Olson et al. | May 2014 | B2 |
8725269 | Nolan et al. | May 2014 | B2 |
8738141 | Smith et al. | May 2014 | B2 |
8738148 | Olson et al. | May 2014 | B2 |
8750985 | Parramon et al. | Jun 2014 | B2 |
8761897 | Kaula et al. | Jun 2014 | B2 |
8768452 | Gerber | Jul 2014 | B2 |
8774912 | Gerber | Jul 2014 | B2 |
8855767 | Faltys et al. | Oct 2014 | B2 |
8918174 | Woods et al. | Dec 2014 | B2 |
8954148 | Labbe et al. | Feb 2015 | B2 |
8989861 | Su et al. | Mar 2015 | B2 |
9044592 | Imran et al. | Jun 2015 | B2 |
9050473 | Woods et al. | Jun 2015 | B2 |
9089712 | Joshi et al. | Jul 2015 | B2 |
9108063 | Olson et al. | Aug 2015 | B2 |
9144680 | Kaula et al. | Sep 2015 | B2 |
9149635 | Denison et al. | Oct 2015 | B2 |
9155885 | Wei et al. | Oct 2015 | B2 |
9166321 | Smith et al. | Oct 2015 | B2 |
9166441 | Dearden et al. | Oct 2015 | B2 |
9168374 | Su | Oct 2015 | B2 |
9192763 | Gerber et al. | Nov 2015 | B2 |
9197173 | Denison et al. | Nov 2015 | B2 |
9199075 | Westlund | Dec 2015 | B1 |
9205255 | Strother et al. | Dec 2015 | B2 |
9209634 | Cottrill et al. | Dec 2015 | B2 |
9216294 | Bennett et al. | Dec 2015 | B2 |
9227055 | Wahlstrand et al. | Jan 2016 | B2 |
9227076 | Sharma et al. | Jan 2016 | B2 |
9238135 | Goetz et al. | Jan 2016 | B2 |
9240630 | Joshi | Jan 2016 | B2 |
9242090 | Atalar et al. | Jan 2016 | B2 |
9244898 | Vamos et al. | Jan 2016 | B2 |
9248292 | Trier et al. | Feb 2016 | B2 |
9259578 | Torgerson et al. | Feb 2016 | B2 |
9259582 | Joshi et al. | Feb 2016 | B2 |
9265958 | Joshi et al. | Feb 2016 | B2 |
9270134 | Gaddam et al. | Feb 2016 | B2 |
9272140 | Gerber et al. | Mar 2016 | B2 |
9283394 | Whitehurst et al. | Mar 2016 | B2 |
9295851 | Gordon et al. | Mar 2016 | B2 |
9308022 | Chitre et al. | Apr 2016 | B2 |
9308382 | Strother et al. | Apr 2016 | B2 |
9314616 | Wells et al. | Apr 2016 | B2 |
9319777 | Aoki et al. | Apr 2016 | B2 |
9320899 | Parramon et al. | Apr 2016 | B2 |
9333339 | Weiner | May 2016 | B2 |
9352148 | Stevenson et al. | May 2016 | B2 |
9352150 | Stevenson et al. | May 2016 | B2 |
9358039 | Kimmel et al. | Jun 2016 | B2 |
9364658 | Wechter | Jun 2016 | B2 |
9375574 | Kaula et al. | Jun 2016 | B2 |
9393423 | Parramon et al. | Jul 2016 | B2 |
9399137 | Parker et al. | Jul 2016 | B2 |
9409020 | Parker | Aug 2016 | B2 |
9415211 | Bradley et al. | Aug 2016 | B2 |
9427571 | Sage et al. | Aug 2016 | B2 |
9427573 | Gindele et al. | Aug 2016 | B2 |
9433783 | Wei et al. | Sep 2016 | B2 |
9436481 | Drew | Sep 2016 | B2 |
9446245 | Grill et al. | Sep 2016 | B2 |
9463324 | Olson et al. | Oct 2016 | B2 |
9468755 | Westlund et al. | Oct 2016 | B2 |
9471753 | Kaula et al. | Oct 2016 | B2 |
9480846 | Strother et al. | Nov 2016 | B2 |
9492672 | Vamos et al. | Nov 2016 | B2 |
9492675 | Torgerson et al. | Nov 2016 | B2 |
9492678 | Chow | Nov 2016 | B2 |
9498628 | Kaemmerer et al. | Nov 2016 | B2 |
9502754 | Zhao et al. | Nov 2016 | B2 |
9504830 | Kaula et al. | Nov 2016 | B2 |
9522282 | Chow et al. | Dec 2016 | B2 |
9592389 | Moffitt | Mar 2017 | B2 |
9597522 | Meskens | Mar 2017 | B2 |
9610449 | Kaula et al. | Apr 2017 | B2 |
9615744 | Denison et al. | Apr 2017 | B2 |
9623257 | Olson et al. | Apr 2017 | B2 |
9636497 | Bradley et al. | May 2017 | B2 |
9643004 | Gerber | May 2017 | B2 |
9653935 | Cong et al. | May 2017 | B2 |
9656074 | Simon et al. | May 2017 | B2 |
9656076 | Trier et al. | May 2017 | B2 |
9656089 | Yip et al. | May 2017 | B2 |
9675809 | Chow | Jun 2017 | B2 |
9687649 | Thacker | Jun 2017 | B2 |
9707405 | Shishilla et al. | Jul 2017 | B2 |
9713706 | Gerber | Jul 2017 | B2 |
9717900 | Swoyer et al. | Aug 2017 | B2 |
9724526 | Strother et al. | Aug 2017 | B2 |
9731116 | Chen | Aug 2017 | B2 |
9737704 | Wahlstrand et al. | Aug 2017 | B2 |
9744347 | Chen et al. | Aug 2017 | B2 |
9750930 | Chen | Sep 2017 | B2 |
9757555 | Novotny et al. | Sep 2017 | B2 |
9764147 | Torgerson | Sep 2017 | B2 |
9767255 | Kaula et al. | Sep 2017 | B2 |
9776002 | Parker et al. | Oct 2017 | B2 |
9776006 | Parker et al. | Oct 2017 | B2 |
9776007 | Kaula et al. | Oct 2017 | B2 |
9780596 | Dearden et al. | Oct 2017 | B2 |
9782596 | Vamos et al. | Oct 2017 | B2 |
9814884 | Parker et al. | Nov 2017 | B2 |
9821112 | Olson et al. | Nov 2017 | B2 |
9827415 | Stevenson et al. | Nov 2017 | B2 |
9827424 | Kaula et al. | Nov 2017 | B2 |
9833614 | Gliner | Dec 2017 | B1 |
9849278 | Spinelli et al. | Dec 2017 | B2 |
9855438 | Parramon et al. | Jan 2018 | B2 |
9872988 | Kaula et al. | Jan 2018 | B2 |
9878165 | Wilder et al. | Jan 2018 | B2 |
9878168 | Shishilla et al. | Jan 2018 | B2 |
9882420 | Cong et al. | Jan 2018 | B2 |
9884198 | Parker | Feb 2018 | B2 |
9889292 | Gindele et al. | Feb 2018 | B2 |
9889293 | Siegel et al. | Feb 2018 | B2 |
9889306 | Stevenson et al. | Feb 2018 | B2 |
9895532 | Kaula et al. | Feb 2018 | B2 |
9899778 | Hanson et al. | Feb 2018 | B2 |
9901284 | Olsen et al. | Feb 2018 | B2 |
9901740 | Drees et al. | Feb 2018 | B2 |
9907476 | Bonde et al. | Mar 2018 | B2 |
9907955 | Bakker et al. | Mar 2018 | B2 |
9907957 | Woods et al. | Mar 2018 | B2 |
9924904 | Cong et al. | Mar 2018 | B2 |
9931513 | Kelsch et al. | Apr 2018 | B2 |
9931514 | Frysz et al. | Apr 2018 | B2 |
9950171 | Johanek et al. | Apr 2018 | B2 |
9974108 | Polefko | May 2018 | B2 |
9974949 | Thompson et al. | May 2018 | B2 |
9981121 | Seifert et al. | May 2018 | B2 |
9981137 | Eiger | May 2018 | B2 |
9987493 | Torgerson et al. | Jun 2018 | B2 |
9993650 | Seitz et al. | Jun 2018 | B2 |
9999765 | Stevenson | Jun 2018 | B2 |
10004910 | Gadagkar et al. | Jun 2018 | B2 |
10016596 | Stevenson et al. | Jul 2018 | B2 |
10027157 | Labbe et al. | Jul 2018 | B2 |
10045764 | Scott et al. | Aug 2018 | B2 |
10046164 | Gerber | Aug 2018 | B2 |
10047782 | Sage et al. | Aug 2018 | B2 |
10052490 | Kaula et al. | Aug 2018 | B2 |
10065044 | Sharma et al. | Sep 2018 | B2 |
10071247 | Childs | Sep 2018 | B2 |
10076661 | Wei et al. | Sep 2018 | B2 |
10076667 | Kaula et al. | Sep 2018 | B2 |
10083261 | Kaula et al. | Sep 2018 | B2 |
10086191 | Bonde et al. | Oct 2018 | B2 |
10086203 | Kaemmerer | Oct 2018 | B2 |
10092747 | Sharma et al. | Oct 2018 | B2 |
10092749 | Stevenson et al. | Oct 2018 | B2 |
10095837 | Corey et al. | Oct 2018 | B2 |
10099051 | Stevenson et al. | Oct 2018 | B2 |
10103559 | Cottrill et al. | Oct 2018 | B2 |
10109844 | Dai et al. | Oct 2018 | B2 |
10118037 | Kaula et al. | Nov 2018 | B2 |
10124164 | Stevenson et al. | Nov 2018 | B2 |
10124171 | Kaula et al. | Nov 2018 | B2 |
10124179 | Norton et al. | Nov 2018 | B2 |
10141545 | Kraft et al. | Nov 2018 | B2 |
10173062 | Parker | Jan 2019 | B2 |
10179241 | Walker et al. | Jan 2019 | B2 |
10179244 | Lebaron et al. | Jan 2019 | B2 |
10183162 | Johnson et al. | Jan 2019 | B2 |
10188857 | North et al. | Jan 2019 | B2 |
10195419 | Shiroff et al. | Feb 2019 | B2 |
10206710 | Kern et al. | Feb 2019 | B2 |
10213229 | Chitre et al. | Feb 2019 | B2 |
10220210 | Walker et al. | Mar 2019 | B2 |
10226617 | Finley et al. | Mar 2019 | B2 |
10226636 | Gaddam et al. | Mar 2019 | B2 |
10236709 | Decker et al. | Mar 2019 | B2 |
10238863 | Gross et al. | Mar 2019 | B2 |
10238877 | Kaula et al. | Mar 2019 | B2 |
10244956 | Kane | Apr 2019 | B2 |
10245434 | Kaula et al. | Apr 2019 | B2 |
10258800 | Perryman et al. | Apr 2019 | B2 |
10265532 | Carcieri et al. | Apr 2019 | B2 |
10277055 | Peterson et al. | Apr 2019 | B2 |
10293168 | Bennett et al. | May 2019 | B2 |
10328253 | Wells | Jun 2019 | B2 |
10363419 | Simon et al. | Jul 2019 | B2 |
10369275 | Olson et al. | Aug 2019 | B2 |
10369370 | Shishilla et al. | Aug 2019 | B2 |
10376701 | Kaula et al. | Aug 2019 | B2 |
10447083 | Dearden et al. | Oct 2019 | B2 |
10448889 | Gerber et al. | Oct 2019 | B2 |
10456574 | Chen et al. | Oct 2019 | B2 |
10471262 | Perryman et al. | Nov 2019 | B2 |
10485970 | Gerber et al. | Nov 2019 | B2 |
10493282 | Caparso et al. | Dec 2019 | B2 |
10493287 | Yoder et al. | Dec 2019 | B2 |
10561835 | Gerber | Feb 2020 | B2 |
10971950 | Dearden et al. | Apr 2021 | B2 |
20020040185 | Atalar et al. | Apr 2002 | A1 |
20020051550 | Leysieffer | May 2002 | A1 |
20020051551 | Leysieffer et al. | May 2002 | A1 |
20020062141 | Moore | May 2002 | A1 |
20020116042 | Boling | Aug 2002 | A1 |
20020140399 | Echarri et al. | Oct 2002 | A1 |
20020177884 | Ahn et al. | Nov 2002 | A1 |
20030028072 | Fischell et al. | Feb 2003 | A1 |
20030078633 | Firlik et al. | Apr 2003 | A1 |
20030114899 | Woods et al. | Jun 2003 | A1 |
20030212440 | Boveja | Nov 2003 | A1 |
20040098068 | Carbunaru et al. | May 2004 | A1 |
20040106963 | Tsukamoto et al. | Jun 2004 | A1 |
20040210290 | Omar-Pasha | Oct 2004 | A1 |
20040250820 | Forsell | Dec 2004 | A1 |
20040267137 | Peszynski et al. | Dec 2004 | A1 |
20050004619 | Wahlstrand et al. | Jan 2005 | A1 |
20050004621 | Boveja et al. | Jan 2005 | A1 |
20050021108 | Klosterman et al. | Jan 2005 | A1 |
20050075693 | Toy et al. | Apr 2005 | A1 |
20050075694 | Schmeling et al. | Apr 2005 | A1 |
20050075696 | Forsberg et al. | Apr 2005 | A1 |
20050075697 | Olson et al. | Apr 2005 | A1 |
20050075698 | Phillips et al. | Apr 2005 | A1 |
20050075699 | Olson et al. | Apr 2005 | A1 |
20050075700 | Schommer et al. | Apr 2005 | A1 |
20050104577 | Matei et al. | May 2005 | A1 |
20050187590 | Boveja et al. | Aug 2005 | A1 |
20060016452 | Goetz et al. | Jan 2006 | A1 |
20060050539 | Yang et al. | Mar 2006 | A1 |
20060142822 | Tulgar | Jun 2006 | A1 |
20060149345 | Boggs et al. | Jul 2006 | A1 |
20060200205 | Haller | Sep 2006 | A1 |
20060206166 | Weiner | Sep 2006 | A1 |
20060247737 | Olson et al. | Nov 2006 | A1 |
20060253173 | Tseng et al. | Nov 2006 | A1 |
20070032836 | Thrope et al. | Feb 2007 | A1 |
20070060968 | Strother et al. | Mar 2007 | A1 |
20070060980 | Strother et al. | Mar 2007 | A1 |
20070073357 | Rooney et al. | Mar 2007 | A1 |
20070185546 | Tseng et al. | Aug 2007 | A1 |
20070239224 | Bennett et al. | Oct 2007 | A1 |
20070265675 | Lund et al. | Nov 2007 | A1 |
20070293914 | Woods et al. | Dec 2007 | A1 |
20080065182 | Strother et al. | Mar 2008 | A1 |
20080082135 | Arcot-Krishnam et al. | Apr 2008 | A1 |
20080132961 | Jaax et al. | Jun 2008 | A1 |
20080132969 | Bennett et al. | Jun 2008 | A1 |
20080154335 | Thrope et al. | Jun 2008 | A1 |
20080161874 | Bennett et al. | Jul 2008 | A1 |
20080172109 | Rahman et al. | Jul 2008 | A1 |
20080183236 | Gerber | Jul 2008 | A1 |
20080278974 | Wu | Nov 2008 | A1 |
20090088816 | Harel et al. | Apr 2009 | A1 |
20090105785 | Wei et al. | Apr 2009 | A1 |
20090112291 | Wahlstrand et al. | Apr 2009 | A1 |
20090227829 | Burnett et al. | Sep 2009 | A1 |
20090259273 | Figueiredo et al. | Oct 2009 | A1 |
20100076254 | Jimenez et al. | Mar 2010 | A1 |
20100076516 | Padiy et al. | Mar 2010 | A1 |
20100076534 | Mock | Mar 2010 | A1 |
20100100158 | Thrope et al. | Apr 2010 | A1 |
20100274319 | Meskens | Oct 2010 | A1 |
20110004269 | Strother et al. | Jan 2011 | A1 |
20110009924 | Meskens | Jan 2011 | A1 |
20110084656 | Gao | Apr 2011 | A1 |
20110152959 | Sherwood et al. | Jun 2011 | A1 |
20110160799 | Mishra et al. | Jun 2011 | A1 |
20110193688 | Forsell | Aug 2011 | A1 |
20110234155 | Chen et al. | Sep 2011 | A1 |
20110257701 | Strother et al. | Oct 2011 | A1 |
20110270269 | Swoyer et al. | Nov 2011 | A1 |
20110278948 | Forsell | Nov 2011 | A1 |
20110282416 | Hamann et al. | Nov 2011 | A1 |
20110301667 | Olson et al. | Dec 2011 | A1 |
20120016447 | Zhu et al. | Jan 2012 | A1 |
20120041512 | Weiner | Feb 2012 | A1 |
20120046712 | Woods et al. | Feb 2012 | A1 |
20120071950 | Archer | Mar 2012 | A1 |
20120119698 | Karalis et al. | May 2012 | A1 |
20120123505 | Kothandaraman | May 2012 | A1 |
20120130448 | Woods et al. | May 2012 | A1 |
20120150259 | Meskens | Jun 2012 | A1 |
20120245649 | Bohori et al. | Sep 2012 | A1 |
20120259381 | Smith et al. | Oct 2012 | A1 |
20120262108 | Olson et al. | Oct 2012 | A1 |
20120274270 | Dinsmoor et al. | Nov 2012 | A1 |
20120276854 | Joshi et al. | Nov 2012 | A1 |
20120276856 | Joshi et al. | Nov 2012 | A1 |
20120283800 | Perryman et al. | Nov 2012 | A1 |
20130004925 | Labbe et al. | Jan 2013 | A1 |
20130006330 | Wilder et al. | Jan 2013 | A1 |
20130006331 | Weisgarber et al. | Jan 2013 | A1 |
20130023958 | Fell | Jan 2013 | A1 |
20130051083 | Zhao | Feb 2013 | A1 |
20130063084 | Tilvis et al. | Mar 2013 | A1 |
20130096651 | Ozawa et al. | Apr 2013 | A1 |
20130096653 | Winstrom | Apr 2013 | A1 |
20130127404 | Maenpaa | May 2013 | A1 |
20130148768 | Kim | Jun 2013 | A1 |
20130150925 | Vamos et al. | Jun 2013 | A1 |
20130184785 | Aghassian | Jul 2013 | A1 |
20130187478 | Bae et al. | Jul 2013 | A1 |
20130197607 | Wilder et al. | Aug 2013 | A1 |
20130197608 | Eiger | Aug 2013 | A1 |
20130207863 | Joshi | Aug 2013 | A1 |
20130211479 | Olson et al. | Aug 2013 | A1 |
20130218228 | Goossen | Aug 2013 | A1 |
20130241304 | Bae | Sep 2013 | A1 |
20130241306 | Aber et al. | Sep 2013 | A1 |
20130303942 | Damaser et al. | Nov 2013 | A1 |
20130310894 | Trier | Nov 2013 | A1 |
20130331909 | Gerber | Dec 2013 | A1 |
20140028267 | Lee | Jan 2014 | A1 |
20140222112 | Fell | Aug 2014 | A1 |
20140237806 | Smith et al. | Aug 2014 | A1 |
20140266025 | Jakubowski | Sep 2014 | A1 |
20140277268 | Lee | Sep 2014 | A1 |
20140277270 | Parramon et al. | Sep 2014 | A1 |
20150028806 | Dearden et al. | Jan 2015 | A1 |
20150088227 | Shishilla et al. | Mar 2015 | A1 |
20150123608 | Dearden et al. | May 2015 | A1 |
20150214604 | Zhao et al. | Jul 2015 | A1 |
20170197079 | Illegems et al. | Jul 2017 | A1 |
20170340878 | Wahlstrand et al. | Nov 2017 | A1 |
20170353047 | Dearden et al. | Dec 2017 | A1 |
20180021587 | Strother et al. | Jan 2018 | A1 |
20180036477 | Olson et al. | Feb 2018 | A1 |
20190097430 | Bae | Mar 2019 | A1 |
20190269918 | Parker | Sep 2019 | A1 |
20190351244 | Shishilla et al. | Nov 2019 | A1 |
20190358395 | Olson et al. | Nov 2019 | A1 |
20200106302 | Dearden et al. | Apr 2020 | A1 |
20210001115 | Wolf, II | Jan 2021 | A1 |
Number | Date | Country |
---|---|---|
520440 | Sep 2011 | AT |
4664800 | Nov 2000 | AU |
5123800 | Nov 2000 | AU |
2014296323 | Jul 2019 | AU |
2371378 | Nov 2000 | CA |
2554676 | Sep 2005 | CA |
101583307 | Nov 2009 | CN |
101980412 | Feb 2011 | CN |
105263571 | Jan 2016 | CN |
105263571 | Jun 2017 | CN |
3146182 | Jun 1983 | DE |
102010006837 | Aug 2011 | DE |
0656218 | Jun 1995 | EP |
1205004 | May 2002 | EP |
1680182 | Jul 2006 | EP |
1904153 | Apr 2008 | EP |
2243509 | Oct 2010 | EP |
3027270 | Jun 2016 | EP |
2395128 | Feb 2013 | ES |
1098715 | Mar 2012 | HK |
2000197275 | Jul 2000 | JP |
3212134 | Sep 2001 | JP |
2002198743 | Jul 2002 | JP |
2003047179 | Feb 2003 | JP |
2007268293 | Oct 2007 | JP |
4125357 | Jul 2008 | JP |
2012210117 | Oct 2012 | JP |
2013530668 | Jul 2013 | JP |
2016533152 | Oct 2016 | JP |
96040367 | May 1996 | WO |
9809588 | Mar 1998 | WO |
9820933 | May 1998 | WO |
9906108 | Feb 1999 | WO |
9918879 | Apr 1999 | WO |
9934870 | Jul 1999 | WO |
9942173 | Aug 1999 | WO |
0056677 | Sep 2000 | WO |
0065682 | Nov 2000 | WO |
0066221 | Nov 2000 | WO |
0069012 | Nov 2000 | WO |
01037926 | May 2001 | WO |
0183029 | Nov 2001 | WO |
0203408 | Jan 2002 | WO |
0209808 | Feb 2002 | WO |
02094139 | Nov 2002 | WO |
03022359 | Mar 2003 | WO |
2004021876 | Mar 2004 | WO |
2004022130 | May 2004 | WO |
2004103465 | Dec 2004 | WO |
2005037364 | Apr 2005 | WO |
2005037365 | Apr 2005 | WO |
2005037370 | Apr 2005 | WO |
2005039698 | May 2005 | WO |
2005079295 | Sep 2005 | WO |
2005081740 | Sep 2005 | WO |
2007015599 | Feb 2007 | WO |
2007081714 | Jul 2007 | WO |
2007136657 | Nov 2007 | WO |
2008021524 | Feb 2008 | WO |
2008038202 | Apr 2008 | WO |
2008151059 | Dec 2008 | WO |
2009051539 | Apr 2009 | WO |
2009055856 | May 2009 | WO |
2009091267 | Jul 2009 | WO |
2009134471 | Nov 2009 | WO |
2010042055 | Apr 2010 | WO |
2010042056 | Apr 2010 | WO |
2010042057 | Apr 2010 | WO |
2011059565 | May 2011 | WO |
2011090736 | Jul 2011 | WO |
2011119352 | Sep 2011 | WO |
2012044103 | Apr 2012 | WO |
2012067971 | May 2012 | WO |
2012103519 | Aug 2012 | WO |
2012129061 | Sep 2012 | WO |
2013018787 | Feb 2013 | WO |
2013038617 | Mar 2013 | WO |
2013072553 | May 2013 | WO |
2013109605 | Jul 2013 | WO |
2013141884 | Sep 2013 | WO |
2015017475 | Feb 2015 | WO |
2015017475 | Apr 2015 | WO |
Entry |
---|
US 9,601,939 B2, 03/2017, Cong et al. (withdrawn) |
Bu-802a: How Does Rising Internal Resistance Affect Performance? Understanding the Importance of Low Conductivity, BatteryUniversity.com, Available Online at https://batteryuniversity.com/learn/article/rising_internal_resistance, Accessed from Internet on: May 15, 2020, 10 pages. |
DOE Handbook: Primer on Lead-Acid Storage Batteries, U.S. Dept. of Energy, Available Online at: htt12s://www.stan dards.doe.gov/standards- documents/ I 000/1084-bhdbk-1995/@@images/file, Sep. 1995, 54 pages. |
Medical Electrical Equipment—Part 1: General Requirements for Safety, British Standard, BS EN 60601-1:1990-BS5724-1:1989, Mar. 1979, 200 pages. |
Summary of Safety and Effectiveness, Medtronic InterStim System for Urinary Control, Apr. 15, 1999, pp. 1-18. |
The Advanced Bionics PRECISION™ Spinal Cord Stimulator System, Advanced Bionics Corporation, Apr. 27, 2004, pp. 1-18. |
UL Standard for Safety for Medical and Dental Equipment, UL 544, 4th edition, Dec. 30, 1998, 128 pages. |
Barnhart et al., “A Fixed-Rate Rechargeable Cardiac Pacemaker”, APL Technical Digest, Jan.-Feb. 1970, pp. 2-9. |
Benditt et al., “A Combined Atrial/Ventricular Lead for Permanent Dual-Chamber Cardiac Pacing Applications”, Chest, vol. 83, No. 6, Jun. 1983, pp. 929-931. |
Boiocchi et al., “Self-Calibration in High Speed Current Steering CMOS D/A Converters”, Advanced A-D and D-A Conversion Techniques and their Applications, Second International Conference on Cambridge, Jul. 1994, pp. 148-152. |
Bosch et al., “Sacral (S3) Segmental Nerve Stimulation as a Treatment for Urge Incontinence in Patients with Detrusor Instability: Results of Chronic Electrical Stimulation Using an Implantable Neural Prosthesis”, The Journal of Urology, vol. 154, No. 2, Aug. 1995, pp. 504-507. |
Boyce et al., “Research Related to the Development of an Artificial Electrical Stimulator for the Paralyzed Human Bladder: a Review”, The Journal of Urology, vol. 91, No. 1, Jan. 1964, pp. 41-51. |
Bradley et al., “Further Experience With the Radio Transmitter Receiver Unit for the Neurogenic Bladder”, Journal of Neurosurgery, vol. 20, No. 11, Nov. 1963, pp. 953-960. |
Broggi et al., “Electrical Stimulation of the Gasserian Ganglion for Facial Pain: Preliminary Results”, Acta Neurochirurgica, vol. 39, 1987, pp. 144-146. |
Cameron et al., “Effects of Posture on Stimulation Parameters in Spinal Cord Stimulation”, Neuromodulation, vol. 1, No. 4, Oct. 1998, pp. 177-183. |
Connelly et al., “Atrial Pacing Leads Following Open Heart Surgery: Active or Passive Fixation?”, Pacing and Clinical Electrophysiology, vol. 20, No. 10, Oct. 1997, pp. 2429-2433. |
Fischell , “The Development of Implantable Medical Devices at the Applied Physics Laboratory”, Johns Hopkins APL Technical Digest, vol. 13 No. 1, 1992, pp. 233-243. |
Gaunt et al., “Control of Urinary Bladder Function With Devices: Successes and Failures”, Progress in Brain Research, vol. 152, 2006, pp. 1-24. |
Ghovanloo et al., “A Small Size Large Voltage Compliance Programmable Current Source for Biomedical Implantable Microstimulators”, Proceedings of the 25th Annual International Conference of the IEEE EMBS, Sep. 17-21, 2003, pp. 1979-1982. |
Gudnason , “A Low-Power ASK Demodulator for Inductively Coupled Implantable Electronics”, Solid-State Circuits Conference, Esscirc ''00, Proceedings of the 26rd European, IEEE, Sep. 2000, 4 pages. |
Helland , “Technical Improvements to be Achieved by the Year 2000: Leads and Connector Technology”, Rate Adaptive Cardiac Pacing, Springer Verlag, 1993, pp. 279-292. |
Hidefjall , “The Pace of Innovation-Patterns of Innovation in the Cardiac Pacemaker Industry”, Linkoping University Press, 1997, 398 pages. |
Ishihara et al., “A Comparative Study of Endocardial Pacemaker Leads”, Cardiovascular Surgery, Nagoya Ekisaikai Hospital, 1st Dept. of Surgery, Nagoya University School of Medicine, 1981, pp. 132-135. |
Jonas et al., “Studies on the Feasibility of Urinary Bladder Evacuation by Direct Spinal Cord Stimulation. I. Parameters of Most Effective Stimulation”, Investigative urology, vol. 13, No. 2, 1975, pp. 142-150. |
Kakuta et al., “In Vivo Long Term Evaluation of Transcutaneous Energy Transmission for Totally Implantable Artificial Heart”, ASAIO Journal, Mar.-Apr. 2000, pp. 1-2. |
Kester et al., “Voltage-to-Frequency Converters”, Available Online at: https://www.analog.com/media/cn/training-seminars/tutorials/MT-028.pdf, 7 pages. |
Lazorthes et al., “Chronic Stimulation of the Gasserian Ganglion for Treatment of Atypical Facial Neuralgia”, Pacing and Clinical Electrophysiology, vol. 10, Jan.-Feb. 1987, pp. 257-265. |
Lewis et al., “Early Clinical Experience with the Rechargeable Cardiac Pacemaker”, The Annals of Thoracic Surgery, vol. 18, No. 5, Nov. 1974, pp. 490-493. |
Love et al., “Experimental Testing of a Permanent Rechargeable Cardiac Pacemaker”, The Annals of Thoracic Surgery, vol. 17, No. 2, Feb. 1, 1974, pp. 152-156. |
Love , “Pacemaker Troubleshooting and Follow-up”, Clinical Cardiac Pacing, Defibrillation, and Resynchronization Therapy, Chapter 24, 2007, pp. 1005-1062. |
Madigan et al., “Difficulty of Extraction of Chronically Implanted Tined Ventricular Endocardial Leads”, Journal of the American College of Cardiology, vol. 3, No. 3, Mar. 1984, pp. 724-731. |
Meglio , “Percutaneously Implantable Chronic Electrode for Radiofrequency Stimulation of the Gasserian Ganglion. A Perspective in the Management of Trigeminal Pain”, Acta Neurochirurgica, vol. 33, 1984, pp. 521-525. |
Meyerson , “Alleviation of Atypical Trigeminal Pain by Stimulation of the Gasserian Ganglion via an Implanted Electrode”, Acta Neurochirurgica Supplementum , vol. 30, 1980, pp. 303-309. |
Mitamura et al., “Development of Transcutaneous Energy Transmission System”, Available Online at https://www.researchgate.net/publication/312810915 Ch.28, Jan. 1988, pp. 265-270. |
Nakamura et al., “Biocompatibility and Practicality Evaluations of Transcutaneous Energy Transmission Unit for the Totally Implantable Artifical Heart System”, Journal of Artificial Organs, vol. 27, No. 2, 1998, pp. 347-351. |
Nashold et al., “Electromicturition in Paraplegia. Implantation of a Spinal Neuroprosthesis”, Arch Surg., vol. 104, Feb. 1972, pp. 195-202. |
Painter et al., “Implantation of an Endocardial Tined Lead to Prevent Early Dislodgement”, The Journal of Thoracic and Cardiovascular Surgery, vol. 77, No. 2, Feb. 1979, pp. 249-251. |
Paralikar et al., “A Fully Implantable and Rechargeable Neurostimulation System for Animal Research”, 7th Annual International IEEE EMBS Conference of Neural Engineering, Apr. 22-24, 2015, pp. 418-421. |
Perez , “Lead-Acid Battery State of Charge vs. Voltage”, Available Online at http://www.rencobattery.com/resources/SOC vs-Voltage.pdf, Aug.-Sep. 1993, 5 pages. |
Schaldach et al., “A Long-Lived, Reliable, Rechargeable Cardiac Pacemaker”, Engineering in Medicine, vol. 1: Advances in Pacemaker Technology, 1975, 34 pages. |
Scheuer-Leeser et al., “Polyurethane Leads: Facts and Controversy”, PACE, vol. 6, Mar.-Apr. 1983, pp. 454-458. |
Sivaprakasam et al., “A Variable Range Bi-Phasic Current Stimulus Driver Circuitry for an Implantable Retinal Prosthetic Device”, IEEE Journal of Solid-State Circuits, IEEE Service Center, Piscataway, NJ, USA, vol. 40, No. 3, Mar. 1, 2005, pp. 763-771. |
Smith , “Changing Standards for Medical Equipment”, UL 544 and UL 187 vs. UL 2601 (“Smith”), 2002, 8 pages. |
Tanagho et al., “Bladder Pacemaker: Scientific Basis and Clinical Future”, Urology, vol. 20, No. 6, Dec. 1982, pp. 614-619. |
Tanagho , “Neuromodulation and Neurostimulation: Overview and Future Potential”, Translational Androl Urol, vol. 1, No. 1, 2012, pp. 44-49. |
Torres et al., “Electrostatic Energy-Harvesting and Battery-Charging CMOS System Prototype”, Available Online at: http://rincon mora.gatech.edu/12ublicat/jrnls/tcasi09_hrv_sys.pdf, pp. 1-10. |
Van Paemel , “High-Efficiency Transmission for Medical Implants”, IEEE Solid-State Circuits Magazine, vol. 3, No. 1, Jan. 1, 2011, pp. 47-59. |
Wang et al., “A 140-dB CMRR Low-Noise Instrumentation Amplifier for Neural Signal Sensing”, Circuits and Systems, 2006. APCCAS 2006, IEEE Asia Pacific Conference on IEEE, Piscataway, NZ, USA, Dec. 1, 2006, pp. 696-699. |
Young , “Electrical Stimulation of the Trigeminal Nerve Root for the Treatment of Chronic Facial Pain”, Journal of Neurosurgery, vol. 83, No. 1, Jul. 1995, pp. 72-78. |
Troyk P.R. et al., “Closed-Loop Class E Transcutaneous Power and Data Link for Microimplants,” IEEE Transactiona on Biomedical Engineering, IEEE, USA, vol. 39, No. 6, Jun. 1, 1992, pp. 589-599. |
Yang Zhou et al, “A Novel Design of Transcutaneous Power and Data Bidirectional Transfer System for Biomedical Implants,” Complex Medical Engineering, 2007, CME 2007, IEEE/ICME Int'l Conf. on, IEEE, May 1, 2007, pp. 1441-1444. |
Bashirullah R. et al., “An Optimal Design Methodology for Inductive Power Link With Class-E Amplifier,” IEEE Transactions on Circuits and Systems Part I: Regular Papers, IEEE Service Center, New York, NY, US, vol. 52, No. 5, May 1, 2005, pp. 857-866. |
Sung-Hsin Hsiao et al., “ZCS switched-capacitor bidirectional converters with secondary output power amplifier for biomedical applications,” 2010 Int'l Power Electronics Conference, IPEC-SAPPORO 2010, Sapporo Japan, IEEE, Piscataway, NJ, USA, Jun. 21, 2010, pp. 1628-1634. |
Number | Date | Country | |
---|---|---|---|
20210288524 A1 | Sep 2021 | US |
Number | Date | Country | |
---|---|---|---|
61859471 | Jul 2013 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14446294 | Jul 2014 | US |
Child | 15685874 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16563654 | Sep 2019 | US |
Child | 17189098 | US | |
Parent | 15685874 | Aug 2017 | US |
Child | 16563654 | US |